NON-INVASIVE CANCER SOLUTIONS     
Safe | Accurate | Easy on the Patient

WORLDWIDE

OPERATION ENDGAME

  • Accurate, affordable and NON-INVASIVE Cancer screening;
  • Clinically relevant, NON-INVASIVE test for complete diagnosis of cancer to substitute invasive tissue extraction;
  • NON-INVASIVE biopsy for diagnosis of brain lesions as per WHO classification of brain tumors;
  • Identification of viable treatment options against drug resistant cancers;
  • Risk-free, radiation-free monitoring of treatment response / recurrence;
  • Ultra Personalised Immunotherapy with Autologous Immune Cells.
CLINICAL TRIALS
Sr. No. Name of Trial Particulars of Trial and CTRI Registration Number Trial Status Publication Link(s)
1. RESILIENT

Encyclopedic Tumor Analysis for Treatment of Refractory / Relapsed Solid Organ Cancers.
CTRI/2018/02/011808

Closed Yes CTRI/2018/02/011808
Oncotarget Link
2. RESOLUTE

Detection of Circulating Clusters of Tumor Associated Cells as a Hallmark of Cancer.
CTRI/2019/01/017219

Ongoing Intermediate Data published. CTRI/2019/01/017219
IJC Link
3. TRUBLOOD

Use of Circulating Tumor Associated Cells for Non-invasive Diagnosis, Prognosis and Theranostics for Solid Organ Cancers.
CTRI/2019/01/017219
CTRI/2019/03/017918

Ongoing Intermediate Data published. CTRI/2019/01/017219
CTRI/2019/03/017918
Trublood : Publications
4. LIQUID-IMPACT

Non-invasive Tumor Analysis using Circulating Tumor Associated Cells for Refractory/ Relapsed Solid Organ Cancers.
CTRI/2019/02/017548

Ongoing
Recruitment Ended
Not yet. CTRI/2019/02/017548
5. GLIOMA

Liquid Biopsy for Differential Diagnosis of Suspected Cases of Brain Malignancies.
CTRI/2019/02/017663

Ongoing Interim Data Published. CTRI/2019/02/017663

Oxford
Neuro-Oncology links

1. Pages vi59–vi60
2. Page vi135
3. Page vi153
4. Pages vi157–vi158

6. PROSTATE

Non-invasive Biopsy for Differential Diagnosis for Patients with Suspected Prostate Cancer.
CTRI/2019/02/017863

Ongoing Interim Data Published. CTRI/2019/02/017863
PDF Link

All Trials are privately funded.
Trials at Sr. No. 1 to 5 are the largest of their kind worldwide till date.

We are open to receive proposals for collaborative research in any of the above areas of cancer science from qualified researchers.

CONTACT US

Please contact us for more details.

I have read and understood the terms of use and the privacy policy and I agree.